. 2017 Dec 22;7(1):270–281. doi: 10.1002/cam4.1166

Table 1.

Patient Characteristics and 25(OH)D levels

Variables	Patients (n)	25(OH)D, ng/mL, (median)	P
Total	155	14
Histology
NOS	128	15	0.5
PBML	9	15
TCHR	4	17
Unclassifiable	8	14
Other	6	14
Age
<60 years	60	14	0.8
>60 years	95	15	0.8
Gender
Female	89	13	0.5
Male	66	15	0.5
Body mass index
<25 kg/m²	90	16	0.05
>25 kg/m²	64	11	0.05
Stage
I–II	58	14	0.5
III–IV	97	14	0.5
B‐symptoms
No	108	15	0.05
Yes	44	9	0.05
ECOG
<2	118	16	0.002
≥2	37	10	0.002
IPI risk group
Low (0‐1)	40	17	0.1
Intermediate (2‐3)	110	13
High (4‐5)	5	14
IPI age‐adjusted
Low (0–1)	78	15	0.1
High (2–3)	77	13	0.1
LDH
Normal	72	17	0.0007
Elevated	83	12	0.0007
Albumin, g/dL
≥4	68	18	0.003
<4	87	12	0.003
Hemoglobin, g/dL
≥10	129	15	0.01
<10	26	9	0.01
Time period
January–March	56	13	0.01
April–June	36	11
July–September	36	17
October–December	27	19

NOS indicates not otherwise specified; PBML, primary mediastinal large B‐cell lymphoma; TCHR, T‐cell/histiocyte‐rich large B‐cell lymphoma; Unclassifiable, lymphoma with intermediate characteristics between DLBCL and Burkitt lymphoma. Significant values are indicated in bold.